Skip to main content
Premium Trial:

Request an Annual Quote

Sequenom Wins European Patent for Mass Spec-Based Genotyping

NEW YORK, Dec. 11 (GenomeWeb News) - Sequenom has won a European patent covering "processes for detecting target nucleic acid sequences in a biological sample using mass spectrometry," the company said today.

 

The patent, EP0815261B1, is called "DNA Diagnostics Based on Mass Spectrometry," and "relates to several patents previously issued in the United States.

 

The award validates the technology in 14 European countries: Austria, Belgium, Denmark, Finland, France, Germany, Great Britain, Ireland, Italy, Netherlands, Portugal, Spain, Sweden, and Switzerland, Sequenom said.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.